SCHEMBL12936661

SCHEMBL12936661

CC(C)(O)c1ccc2c(c1)/C(=C/CCN1CCC(Oc3ccc(C(F)(F)P)cc3)CC1)c1cccnc1CO2

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCR1 P32246 2/20 0.56
▸ CHRM2 P08172 1/20 0.41
▸ CCR5 P51681 1/20 0.41
▸ HTR1A P08908 6/20 0.35
▸ SIGMAR1 Q99720 3/20 0.33
▸ KCNK2 O95069 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ TP53 P04637 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ NFKB1 P19838 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ THPO P40225 1/20 0.33
▸ HRH1 P35367 5/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ GMNN O75496 1/20 0.33
▸ LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL656474 0.94 CCR1 (0.57) CCR1CHRM2CCR5HTR1ASIGMAR1
SCHEMBL656475 0.94 CCR1 (0.57) CCR1CHRM2CCR5HTR1ASIGMAR1
SCHEMBL13617088 0.86 CCR1 (0.48) CCR1CHRM2CCR5HTR1ASIGMAR1
SCHEMBL651786 0.85 CCR1 (0.60) CCR1CHRM2CCR5HTR1ASIGMAR1
SCHEMBL651785 0.85 CCR1 (0.60) CCR1CHRM2CCR5HTR1ASIGMAR1
SCHEMBL12121948 0.84 CCR1 (0.68) CCR1CHRM2CCR5SIGMAR1KCNK2
SCHEMBL15478357 0.83 CCR1 (0.63) CCR1CHRM2CCR5SIGMAR1KCNK2
SCHEMBL16312649 0.82 CCR1 (0.62) CCR1CHRM2CCR5SIGMAR1KCNK2
SCHEMBL3836897 0.79 CCR1 (0.60) CCR1CHRM2CCR5HRH1ADRA1D
SCHEMBL3836896 0.79 CCR1 (0.60) CCR1CHRM2CCR5HRH1ADRA1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2286811-A1 Chemokine receptor antagonists and methods of use thereof Millennium Pharmaceuticals, Inc. (US) 2011-02-23 — — EP disclosed
Send feedback